Science Huddle – Cell & Gene Therapy: Maximizing Commercialization

Enjoy an on-demand event featuring a world class line up of experts and scientific leaders discussing Cell & Gene Therapy: Maximizing Commercialization

With so many exciting advances – particularly in gene therapy now – coming out of the labs, developers need to maximize their commercialization potential through optimized planning.

Event Panel:

Keith Thompson, CBE – Chairman of a Natural Killer (NK) cell therapy company, NK:IO, and advisor to Deep Science Ventures (Investors in Pharma).

Michael May ​ – President & CEO of The Centre for Commercialization of Regenerative Medicine (CCRM)

Sven Kili ​ – CEO at Antion Biosciences, a UK-based Multiplex Cell Engineering company

 

Event Moderator:

Dr Christian Schneider – Head of Biopharma Excellence and Chief Medical Officer, Biopharma Excellence

  Go Back

Start a conversation today

Socials:









    By submitting this form, you understand that Cencora may process your data as described in the Cencora Privacy Policy

    We are now Cencora PharmaLex 

    PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

    Know more